Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

GLP1R library

Preferred format:
Desirable size of the custom library selection:
Amount:
Mg
  • Mg
  • uMol
Volume:

GLP1R library 13938 compounds. Discovery of GLP1R agonists.

GLP-1R (Glucagon-like peptide-1 receptor) is a crucial target for therapeutic agent development because its activation plays a significant role in regulating glucose levels and appetite. GLP-1R agonists are used for treating type 2 diabetes and obesity, making the discovery of new, effective compounds particularly important.

The following technologies were employed to identify new potential GLP-1R agonists:

 1. Tanimoto + PhysChem Filters Approach :

  • Physicochemical Filters: Criteria included the number of hydrogen bond donors and acceptors, the log partition coefficient (LogP), molecular weight, the number of rotatable bonds, and total polar surface area (TPSA).

  • ChemDiv Library: Initially contained 1,666,984 compounds, which were filtered down to 85,874 compounds after applying the physicochemical filters.

  • Tanimoto Similarity: Used to search for compounds with a specified similarity, employing threshold values of 0.3 and 0.4 for 256 and 512 bits. This reduced the number of compounds to 4,315.

 2. Molecular Docking:

  • Docking Score: Identifying potential agonists based on their binding affinity to GLP-1R using molecular docking. Compounds with the best docking scores (up to -11) were selected.

 3. Deep Learning:

  •  Deep Learning Model: Trained using data from various patents and public databases to classify active and inactive compounds.
  • Model Architecture: Included three Graph Attention Layers (GAT), a Global Mean Pooling layer, and two fully connected layers with a sigmoid activation function for final classification.

  • Results: The model showed high metrics for accuracy, ROC AUC, and PR AUC, indicating its effectiveness in predicting compound activity.

Combining these methods allowed for narrowing down the compound library to the most promising candidates for further experimental testing and development of new therapeutic agents for diabetes and obesity treatment.






0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company